Life Sciences

With experience in pharmaceuticals, biotechnology, vaccines, medical devices, and technology, Dean & Company has a track record of providing actionable and quantifiable results to clients.

Life Sciences

With experience in pharmaceuticals, biotechnology, vaccines, medical devices, and technology, Dean & Company has a track record of providing actionable and quantifiable results to clients.

Life Sciences

Dean & Company has an established, highly successful track record in generating actionable and quantifiable results for our clients in the Life Sciences. These include a number of the largest global companies as well as emerging leaders in the Pharmaceuticals, Biotechnology, Vaccines, and Medical Devices & Technology industries.

The hallmark of our work in Life Sciences, as in other industries, is our ability to deliver analysis-driven solutions to complex business problems and develop practical, action-oriented recommendations with impact on the bottom-line. Dean & Company’s Life Sciences Practice drives results through the implementation of four key capabilities:

Dean & Company has helped top global biopharma companies, specialty pharma companies, emerging biotechs, medical device companies, public sector institutions, and private equity investors analyze high leverage issues and develop concrete and actionable business strategies. We have also assisted Life Sciences clients on a wide range of issues, including high-level strategic thinking, M&A strategy and due diligence, and key functional initiatives such as customer targeting and channel optimization.

Capabilities